200 related articles for article (PubMed ID: 1991850)
1. Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans.
Saxon A; Macy E; Denis K; Tary-Lehmann M; Witte O; Braun J
J Clin Invest; 1991 Feb; 87(2):658-65. PubMed ID: 1991850
[TBL] [Abstract][Full Text] [Related]
2. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
Williams SS; Umemoto T; Kida H; Repasky EA; Bankert RB
J Immunol; 1992 Oct; 149(8):2830-6. PubMed ID: 1401915
[TBL] [Abstract][Full Text] [Related]
3. Human Ig production and isotype switching in severe combined immunodeficient-human mice.
Vandekerckhove BA; Jones D; Punnonen J; Schols D; Lin HC; Duncan B; Bacchetta R; de Vries JE; Roncarolo MG
J Immunol; 1993 Jul; 151(1):128-37. PubMed ID: 8326122
[TBL] [Abstract][Full Text] [Related]
4. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
Nonoyama S; Smith FO; Ochs HD
J Immunol; 1993 Oct; 151(7):3894-901. PubMed ID: 8376809
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of the heavy chain of antibodies that recognize the capsular polysaccharide of Neisseria meningitidis in hu-PBMC reconstituted SCID mice and in the immunized human donor.
Smithson SL; Srivastava N; Hutchins WA; Westerink MA
Mol Immunol; 1999 Feb; 36(2):113-24. PubMed ID: 10378683
[TBL] [Abstract][Full Text] [Related]
6. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
[TBL] [Abstract][Full Text] [Related]
7. Role of interleukin-4 in human immunoglobulin E formation in hu-PBL-SCID mice.
Spiegelberg HL; Beck L; Kocher HP; Fanslow WC; Lucas AH
J Clin Invest; 1994 Feb; 93(2):711-7. PubMed ID: 8113405
[TBL] [Abstract][Full Text] [Related]
8. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
Shiroki R; Poindexter NJ; Woodle ES; Hussain MS; Mohanakumar T; Scharp DW
Transplantation; 1994 Jun; 57(11):1555-62. PubMed ID: 8009588
[TBL] [Abstract][Full Text] [Related]
9. Human peripheral blood leukocyte-reconstituted severe combined immunodeficient mouse: analysis of the human immune response against porcine islet transplantation.
Shiroki R; Naziruddin B; Shishido S; Duffy BF; Howard T; Mohanakumar T
Transplantation; 1997 Mar; 63(6):818-23. PubMed ID: 9089220
[TBL] [Abstract][Full Text] [Related]
10. Optimisation of human anti-tetanus toxoid antibody responses and location of human cells in SCID mice transplanted with human peripheral blood leucocytes.
Jackson DJ; Kumpel BM
Hum Antibodies; 1997; 8(4):181-8. PubMed ID: 9395920
[TBL] [Abstract][Full Text] [Related]
11. Antibody responses to the blood group antigen D in SCID mice reconstituted with human blood mononuclear cells.
Leader KA; Macht LM; Steers F; Kumpel BM; Elson CJ
Immunology; 1992 Jun; 76(2):229-34. PubMed ID: 1634246
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.
Cao T; Lazdina U; Desombere I; Vanlandschoot P; Milich DR; Sällberg M; Leroux-Roels G
J Virol; 2001 Jul; 75(14):6359-66. PubMed ID: 11413302
[TBL] [Abstract][Full Text] [Related]
13. The hu-PBL-SCID mouse model. Long-term human serologic evolution associated with the xenogeneic transfer of human peripheral blood leukocytes into SCID mice.
Duchosal MA; Eming SA; McConahey PJ; Dixon FJ
Cell Immunol; 1992 Feb; 139(2):468-77. PubMed ID: 1733515
[TBL] [Abstract][Full Text] [Related]
14. Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease.
Duchosal MA; Eming SA; McConahey PJ; Dixon FJ
Am J Pathol; 1992 Nov; 141(5):1097-113. PubMed ID: 1332484
[TBL] [Abstract][Full Text] [Related]
15. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant.
Zhou W; Ohdan H; Tanaka Y; Hara H; Tokita D; Onoe T; Asahara T
Transpl Immunol; 2003; 12(1):9-18. PubMed ID: 14551028
[TBL] [Abstract][Full Text] [Related]
16. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
17. Regulation of human IgE response in hu-PBL-SCID mice.
Kilchherr E; Mandak V; Wagner K; Heusser CH
Cell Immunol; 1993 Oct; 151(2):241-56. PubMed ID: 8402934
[TBL] [Abstract][Full Text] [Related]
18. Establishment of human IgE system in severe combined immunodeficient mice with peripheral blood mononuclear cells from asthmatic children.
Chiang BL; Chou CC; Ding HJ; Huang MS; Chen JM; Hsieh KH
J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):69-76. PubMed ID: 7822666
[TBL] [Abstract][Full Text] [Related]
19. Murine IL-2 receptor beta chain blockade improves human leukocyte engraftment in SCID mice.
Tournoy KG; Depraetere S; Meuleman P; Leroux-Roels G; Pauwels RA
Eur J Immunol; 1998 Oct; 28(10):3221-30. PubMed ID: 9808191
[TBL] [Abstract][Full Text] [Related]
20. Long term substitution and specific immune responses after transfer of bovine peripheral blood lymphocytes into severe combined immunodeficient mice.
Hölscher C; Hasch G; Joswig N; Stauffer U; Müller U; Mossmann H
Vet Immunol Immunopathol; 1999 Sep; 70(1-2):67-83. PubMed ID: 10507288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]